MarketsandMarkets Presents
Apheresis Market worth 2.06 Billion USD by 2021
http://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html
The report "Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) Global Forecast to 2021", The Global Apheresis Market is projected to reach USD 2.06 Billion by 2021, at a CAGR of 7.7% from 2016 to 2021. Browse: 174 market data tables 47 figures 212 pages and in-depth TOC on ÍžApheresis MarketÍ&#x;
Download the PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=950 The rising incidence of chronic lifestyle diseases such as diabetes, kidney disorders, & respiratory diseases, increasing demand for blood components, and favorable reimbursement scenario are the key factors driving the growth of the market http://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html
However, scarcity of qualified donors and the high cost of apheresis machines & procedures are restraining the growth of this market.
Talk to Our Research Experts@ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=950
In this report, the market is majorly segmented by product, procedure, technology, application, and region. Based on product, the market is segmented into devices and disposables.
The disposables segment accounted for the largest share and will be the fastest growing market during the forecast period. This is attributed to the increasing demand for disposables and rising preference for apheresis blood collection. http://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html
On the basis of procedure, the market is segmented into automated/donor apheresis and therapeutic apheresis.
Therapeutic apheresis is further segmented into therapeutic plasma exchange (TPE), therapeutic cytapheresis, photopheresis, and extracorporeal immunoadsorption (ECI). In 2015, therapeutic plasma exchange segment accounted for the largest share of the
market.
The large share of this segment is attributed to the increasing prevalence and incidence of
various blood disorders such as sickle-cell anemia and leukemia. The photopheresis segment is expected to register the highest CAGR during the forecast period due to the increasing demand for photopheresis in organ transplant rejection treatment.
http://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html
In 2015, North America accounted for the largest share of the market, followed by Europe. The presence of established distribution channels, growing applications of apheresis products in plasma collection and fractionation, and rising number of hemophilic patients are driving the growth of the North American apheresis market.
The Asia-Pacific region is expected to witness the highest growth in this market majorly due to improving healthcare infrastructure and growing economies in China and India. In
addition, manufacturers are increasingly focusing on strengthening their presence in emerging APAC countries.
http://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html
The global apheresis market is highly competitive in nature, with the top five companies accounting for the major market share in 2015.
Some of the key players in this market are Haemonetics Corporation (U.S.), Fresenius
Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co.,
Ltd. (Japan). These leading players primarily focused on product launches, acquisitions, agreements, collaborations, partnerships, and expansions to help growth in the market.
http://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html
About MarketsandMarkets™ Marketsa dMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide co pa ies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach Marketsa dMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at Marketsa dMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. Marketsa dMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. . Marketsa dMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
http://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html
Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets